Cost-effectiveness analysis for surgical, angioplasty, or medical therapeutics for coronary artery disease: 5-year follow-up of medicine, angioplasty, or surgery study (MASS) II trial

Circulation

Volumn 126, Issue 11 SUPPL.1, 2012, Pages

  Vieira, Ricardo D'Oliveira ^a   Hueb, Whady ^a   Hlatky, Mark ^b   Favarato, Desiderio ^a   Rezende, Paulo Cury ^a   Garzillo, Cibele Larrosa ^a   Lima, Eduardo Gomes ^a   Soares, Paulo Rogério ^a   Hueb, Alexandre Ciappina ^a   Pereira, Alexandre Costa ^a   Ramires, José Antonio Franchini ^a   Filho, Roberto Kalil ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

coronary artery disease; coronary revascularization; cost effectiveness; multivessel coronary artery disease

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; ANGINA PECTORIS; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART TAMPONADE; HEMODIALYSIS; HOSPITAL COST; HOSPITAL INFECTION; HOSPITALIZATION COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STROKE; SURGICAL MORTALITY; UNSTABLE ANGINA PECTORIS; WOUND INFECTION;

AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; CORONARY DISEASE; COST-BENEFIT ANALYSIS; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; OFFICE VISITS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84866436922     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.084442     Document Type: Article

References (19)

1. Hlatky MA, Boothroyd DB, Bravata D, Boersma E, Booth J, Brooks MM, Carri é D, Clayton TC, Danchin MN, Flather M, Hamm CW, Hueb WA, Kahler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomized trials. Lancet. 2009;373:1190-1197.
2. Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LAC, Jatene FB, Oliveira SA, Ramires JAF. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082-1089.
3. Weintraub WS, Boden WE, Zhang Z, Kolm P, Zhang Z, Spertus JA, Hartigan P, Veledar E, Jurkovitz C, Bowen J, Maron DJ, O'Rourke R, Dada M, Teo KK, Goeree R, Barnett PG. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes. 2008;1:12-20.
4. Hlatky MA, Boothroyd DB, Melsop KA, Kennedy L, Rihal C, Rogers WJ, Venkitachalam L, Brooks MM; for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial. Circulation. 2009;120:2550-2558.
5. Sculpher MJ, Seed P, Henderson RA. Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet. 1994;344:927-930.
6. Weintraub WS, Becker ER, Mauldin PD, Culler S, Kosinski AS, King SB III. Cost of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty Versus Surgery Trial (EAST). Am J Cardiol. 2000;86:747-752.
7. Hlatky MA, Rogers W. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med. 1997;336:92-99.
8. Serruys PW, Unger F, Sousa JE. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117-1124.
9. Chaitman BR, Ryan TJ, Kronmal RA, Foster ED, Frommer PL, Killip T. Coronary Artery Surgery Study (CASS): comparability of 10 year survival in randomized and randomizable patients. J Am Coll Cardiol. 1990;16:1071-1078.
10. Girardi PBMA, Hueb W, Nogueira CRSR, Takiuti ME, Nakano T, Garzillo CL, Paulitsch FS, Góis AFT, Lopes NHM, Stolf NA. Comparative costs between myocardial revascularization with or without extracorporeal circulation. Arq Bras Cardiol. 2008;91:369-376.
11. Favarato D, Hueb W, Gersh BJ, Soares PR, Cesar LA, da Luz PL, Oliveira SA, Ramires JA. Relative cost comparison of treatments for coronary artery disease: the first year follow-up of MASS II study. Circulation. 2003;108(suppl II):21-23.
12. Hueb W, Soares PR, Gersh BJ, Cesar LA, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JA. The Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multi-vessel coronary artery disease: 1-year results J Am Coll Cardiol. 2004;43:1743-1751.
13. Campeau L. Grading of angina pectoris. Circulation. 1976;54:522-523. Letter.
14. Serruys PW, Unger F, van Hout BA, van den Brand MJ, van Herwerden LA, van Es GA, Bonnier JJRM, Simon R, Cremer J, Colombo A, Santoli C, Vandormael M, Marshall PR, Madonna O, Firth BG, Breeman A, Morel MA, Hugenholtz PG. The ARTS (Arterial Revascularization Therapies Study): background, goals and methods. Int J Cardiovasc Interv. 1999;2:41-50.
15. Hlatky MA, Owensb DK, Sandersc GD. Cost-effectiveness as an outcome in randomized clinical trials. Clinical Trials. 2006;3:543-551.
16. Cohen DJ, Reynolds MR. Interpreting the results of cost-effectiveness studies. J Am Coll Cardiol. 2008;52:2119-2126.
17. Murraya CJL, Evansa DB, Acharyab A, Baltussenc RMPM. Development of who guidelines on generalized cost-effectiveness analysis. Health Econ. 2000;9:235-251.
18. Bell CM, Urbach DR, Ray JG, Bayoumi A, Rosen AB, Greenberg D, Neumann PJ. Bias in published cost effectiveness studies: systematic review. BMJ. 2006;332:699-703.
19. Sculpher MJ, Smith DH, Clayton T, Henderson RA, Buxton MJ, Pocock SJ, Chamberlain DA; Randomized Intervention Treatment of Angina (RITA-2) Trial. Coronary angioplasty versus medical therapy for angina: health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial. Eur Heart J. 2002;23:1291-1300.